These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 1715094)

  • 1. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
    Heitman J; Movva NR; Hall MN
    Science; 1991 Aug; 253(5022):905-9. PubMed ID: 1715094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.
    Benton BM; Zang JH; Thorner J
    J Cell Biol; 1994 Nov; 127(3):623-39. PubMed ID: 7525596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae.
    Heitman J; Movva NR; Hiestand PC; Hall MN
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1948-52. PubMed ID: 1705713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC; Heitman J
    J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
    Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
    Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13.
    Jin YJ; Albers MW; Lane WS; Bierer BE; Schreiber SL; Burakoff SJ
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6677-81. PubMed ID: 1713687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
    Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
    Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
    Kunz J; Henriquez R; Schneider U; Deuter-Reinhard M; Movva NR; Hall MN
    Cell; 1993 May; 73(3):585-96. PubMed ID: 8387896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
    Helliwell SB; Wagner P; Kunz J; Deuter-Reinhard M; Henriquez R; Hall MN
    Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity.
    Cardenas ME; Heitman J
    EMBO J; 1995 Dec; 14(23):5892-907. PubMed ID: 8846782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
    Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin.
    Michnick SW; Rosen MK; Wandless TJ; Karplus M; Schreiber SL
    Science; 1991 May; 252(5007):836-9. PubMed ID: 1709301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1.
    Brizuela L; Chrebet G; Bostian KA; Parent SA
    Mol Cell Biol; 1991 Sep; 11(9):4616-26. PubMed ID: 1715022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
    Cafferkey R; Young PR; McLaughlin MM; Bergsma DJ; Koltin Y; Sathe GM; Faucette L; Eng WK; Johnson RK; Livi GP
    Mol Cell Biol; 1993 Oct; 13(10):6012-23. PubMed ID: 8413204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing immunosuppressant action with a nonnatural immunophilin ligand.
    Bierer BE; Somers PK; Wandless TJ; Burakoff SJ; Schreiber SL
    Science; 1990 Oct; 250(4980):556-9. PubMed ID: 1700475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
    Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
    Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
    Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
    J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of a FKBP-type immunophilin from higher plants.
    Luan S; Kudla J; Gruissem W; Schreiber SL
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6964-9. PubMed ID: 8692927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.